Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review

被引:17
作者
Franchini, Massimo [1 ]
Capuzzo, Enrico [1 ]
Liumbruno, Giancarlo M. [2 ]
机构
[1] Carlo Poma Hosp, Dept Haematol & Transfus Med, Mantua, Italy
[2] Italian Natl Blood Ctr, Natl Inst Hlth, Rome, Italy
关键词
lipoprotein apheresis; lipoprotein(a); thrombosis; TRANSFER PROTEIN INHIBITOR; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; LIPID APHERESIS; DOUBLE-BLIND; RISK-FACTOR; LDL-C; SAFETY; EFFICACY;
D O I
10.2450/2015.0163-15
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein(a), which consists of a low-density lipoprotein (LDL) particle linked to an apolipoprotein(a) moiety, is currently considered an independent risk factor for cardiovascular disease due to its atherogenic (LDL-like) and prothrombotic (plasminogen-like) properties. The aim of this review is to provide an overview of the current and newer therapies for lowering increased lipoprotein(a) levels, focusing on lipoprotein apheresis. After a systematic literature search, we identified ten studies which, overall, documented that lipoprotein apheresis is effective in reducing increased lipoprotein(a) levels and cardiovascular events.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 50 条
  • [41] Elevated levels of lipoprotein(a) in women with preeclampsia
    Wang, J
    Mimuro, S
    Lahoud, R
    Trudinger, B
    Wang, XL
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (01) : 146 - 149
  • [42] Low-density lipoprotein apheresis as a treatment option for hyperlipidemia
    Mehta P.K.
    Baer J.
    Nell C.
    Sperling L.S.
    Current Treatment Options in Cardiovascular Medicine, 2009, 11 (4) : 279 - 288
  • [43] Lipoprotein apheresis in isolated hyperlipoproteinemia(a): a validated treatment or an illusion of validity?
    Berthold, Heiner K.
    Descamps, Olivier S.
    Gouni-Berthold, Ioanna
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (01) : 108 - 112
  • [44] Clinical characteristics associated with elevated levels of lipoprotein(a) in patients with vascular risk
    Rubio-Serrano, Javier
    Gullon Ojesto, Alejandra
    Suarez Fernandez, Carmen
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (04): : 396 - 401
  • [45] Low birthweight and elevated levels of lipoprotein(a) in prepubertal children
    Rodriguez-Moran, Martha
    Guerrero-Romero, Fernando
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (08) : 610 - 614
  • [46] Living with Elevated Lipoprotein(a) Levels: The Experiences of Patients and Caregivers
    Steinhagen-Thiessen, Elisabeth
    Daccord, Magdalena
    Print, Emma C.
    Wang, Yujiao
    Shipton, Janine
    Rijken, India
    Shipton, Michael
    Perna, Flavia
    Schoenberger, Matthias
    PATIENT PREFERENCE AND ADHERENCE, 2025, 19 : 395 - 405
  • [47] ELEVATED LIPOPROTEIN-(A) LEVELS IN PRIMARY NEPHROTIC SYNDROME
    FAUCHER, C
    DOUCET, C
    BAUMELOU, A
    CHAPMAN, J
    JACOBS, C
    THILLET, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (06) : 808 - 813
  • [48] Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression
    Paslakis, Georgios
    Kopf, Daniel
    Westphal, Sabine
    Gilles, Maria
    Lederbogen, Florian
    Hamann, Bettina
    Heuser, Isabella
    Deuschle, Michael
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (10) : 1344 - 1346
  • [49] Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels
    Eraikhuemen, Nathaniel
    Lazaridis, Dovena
    Dutton, Matthew T.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (03) : 255 - 265
  • [50] Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia
    Connolly, Katherine D.
    Willis, Gareth R.
    Datta, Dev B. N.
    Ellins, Elizabeth A.
    Ladell, Kristin
    Price, David A.
    Guschina, Irina A.
    Rees, D. Aled
    James, Philip E.
    JOURNAL OF LIPID RESEARCH, 2014, 55 (10) : 2064 - 2072